Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

A comparison between ATG and PT-CY graft-versus-host-disease prophylaxis in patients with lymphoma undergoing reduced intensity conditioning regimen HSCT from 1 antigen MMUD

Retrospective Studies

Lymphoma Working Party (LWP)

Type de traitement

Allogeneic - Unrelated

Investigateur principal

Annalisa Paviglianiti

Phase 2 trial to assess haploidentical a/ß T-depleted stem cell transplantation in patients with sickle cell disease with no available sibling donor (T-Haplo-HSCT for SCD)

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogeneic - Haploidentical

Investigateur principal

Selim Corbacioglu

Allogeneic hematopoietic stem cell transplantation for the BCR-ABL1 negative myeloproliferative neoplasms in children

Retrospective Studies

Myeloproliferative Neoplasm (MPN)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Jacek Wachowiak

Thrombopoietin receptor agonists post HSCT in pediatric patients

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Asaf David Yanir

Haploidentical stem cell transplantation using PTCY for children with acute leukemia

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogeneic - Haploidentical

Investigateur principal

Annalisa Ruggeri

Use of eculizumab to treat thrombotic microangiopathy associated with haematopoietic stem cell transplantation - a retrospective study on behalf of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Pregnancy rates and Pregnancy outcomes after hematopoietic stem cell transplantation in childhood

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Tamara Diesch-Furlanetto

Retrospective analysis on the outcome of autologous and allogeneic stem cell transplantation in children and adolescents with non-anaplastic peripheral T-cell lymphoma

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Haematopoietic stem cell transplantation in children and adolescents with non hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Allogeneic stem cell transplantation for refractory AML: a comparison between sequential or standard myeloablative conditioning regimen (a retrospective study).

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Evaluation of the EBMT risk score and of a modified EBMT risk score adapted to paediatric patients in paediatric allogeneic transplantation

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Fanette Bernard

Outcome after allogeneic SCT for MLL-PTD AML

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type de traitement

Investigateur principal

Marta Pratcorona